Mathilde Bahuaud

Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial

Andrew J. Pollard, Odile Launay, Jean‐Daniel Lelièvre et al. · The Lancet Infectious Diseases · 2020 · 170 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study

Sodiomon B. Sirima, Laura Richert, Arnaud Chêne et al. · The Lancet Infectious Diseases · 2020 · 129 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Dimethyl Fumarate Controls the NRF2/DJ-1 Axis in Cancer Cells: Therapeutic Applications

Nathaniel Edward Bennett Saidu, Gaëlle Noé, Olivier Cerles et al. · Molecular Cancer Therapeutics · 2017 · 72 citations

Medicine, Cancer Biology, Oncology +16

Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel® in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial

Sodiomon B. Sirima, Christine Durier, Leila Kara et al. · Vaccine · 2017 · 54 citations

Veterinary Medicine, Immunology, Infectious Diseases +15

Pneumococcal vaccination in patients with systemic lupus erythematosus: A multicenter placebo-controlled randomized double-blind study

Sophie Grabar, Matthieu Groh, Mathilde Bahuaud et al. · Vaccine · 2017 · 45 citations

Veterinary Medicine, Immunology, Preventive Medicine +13